CHF Solutions To Exhibit At the American Association of Heart Failure Nurses 15th Annual Meeting
June 25 2019 - 8:30AM
CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting
at the 15th Annual Meeting of the American Association of Heart
Failure Nurses (AAHFN) June 27-29, 2019 at the JW Marriott Austin
in Austin, Texas.
The company will be exhibiting information about its Aquadex
FlexFlow® system at Booth #512 at the JW Marriott Austin throughout
the conference. For more information, please visit
https://www.aahfn.org/mpage/am2019whyattend.
“The American Association of Heart Failure Nurses continues to
be an important venue for CHF Solutions as it is the heart failure
nurse that often leads the day-to-day treatment of heart failure
patients, including the operation of the Aquadex FlexFlow system,”
said John Erb, chairman and CEO of CHF Solutions. “We look forward
to this additional opportunity to educate these essential
healthcare providers regarding the benefits of our device.
These benefits include delivering safe and precise therapy with the
ability to adjust the fluid removal rate and volume to meet each
patient’s clinical need.
About CHF Solutions
CHF Solutions, Inc. (Nasdaq:CHFS) is a medical device company
focused on developing, manufacturing and commercializing the
Aquadex FlexFlow system for aquapheresis therapy. Aquadex FlexFlow
system is a clinically proven therapy that provides a safe,
effective and predictable method of removing excess sodium and
fluid from patients suffering from fluid overload. The Aquadex
FlexFlow system is indicated for temporary (up to eight hours)
ultrafiltration treatment of patients with fluid overload who have
failed diuretic therapy and extended (longer than 8 hours)
ultrafiltration treatment of patients with fluid overload who have
failed diuretic therapy and require hospitalization. All treatments
must be administered by a healthcare provider, under physician
prescription, both of whom having received training in
extracorporeal therapies. The company's vision is to change the
lives of fluid overloaded patients through science, collaboration,
and innovative medical technology. CHF Solutions is a
Delaware corporation headquartered in Minneapolis, Minnesota with
wholly owned subsidiaries in Australia and Ireland. The company has
been listed on the Nasdaq Capital Market since February 2012.
Forward-Looking Statements
Certain statements in this release may be considered
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including without
limitation, the company’s plans for the Annual Meeting of the
American Association of Heart Failure Nurses. Forward-looking
statements are predictions, projections and other statements about
future events that are based on current expectations and
assumptions and, as a result, are subject to risks and
uncertainties. Many factors could cause actual future events to
differ materially from the forward-looking statements in this
release, including, without limitation, those risk associated with
our ability to execute on our commercial strategy, the possibility
that we may be unable to raise sufficient funds necessary for our
anticipated operations, our post-market clinical data collection
activities, benefits of our products to patients, our expectations
with respect to product development and commercialization efforts,
our ability to increase market and physician acceptance of our
products, potentially competitive product offerings, intellectual
property protection, our ability to integrate acquired businesses,
our expectations regarding anticipated synergies with and benefits
from acquired businesses, and other risks and uncertainties
described in our filings with the SEC. Forward-looking statements
speak only as of the date when made. CHF Solutions does not assume
any obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
CONTACTS:
INVESTORS:Claudia Napal DraytonChief Financial
Officer CHF Solutions, Inc.952-345-4205ir@chf-solutions.com
-or-Bret Shapiro Managing Partner CORE
IR516-222-2560brets@coreir.com www.coreir.com
MEDIAJules Abraham JQA Partners, Inc.
917-885-7378jabraham@jqapartners.com
Source: CHF Solutions, Inc.
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Mar 2024 to Apr 2024
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Apr 2023 to Apr 2024